The Renoir Study: Help Fight Respiratory Synctial Virus (RSV)
RSV is a leading cause of respiratory illness in older adults that can lead to hospitalization. No specific prevention or treatment options currently exist.
We’re looking for people who can help us advance an investigational vaccine for RSV.
You may be eligible for the Renoir study if you are 60 years of age or older and generally healthy or have stable chronic conditions. If you qualify and choose to take part, you will be in the study for three RSV seasons (about three years). By participating in the Renoir study, you could be a part of vaccine progress for older adults. DETAILS
Ascension St. John Hospital
Vaccine Research Unit
19251 Mack Avenue, Suite 380
Grosse Pointe Woods, MI 48236